Behavioral health residential businesses provide structured, live-in clinical treatment for individuals with mental health disorders, substance use disorders, or co-occurring dual diagnoses, operating under state licensure and often accreditation requirements. The sector has experienced strong demand driven by increased awareness of mental health conditions, the ongoing opioid epidemic, and expanded insurance coverage mandated by mental health parity laws. The market remains highly fragmented, with thousands of independent owner-operated facilities representing significant consolidation opportunity for regional and national platform builders.
Who buys these: Private equity firms targeting healthcare services, strategic acquirers such as regional or national behavioral health platform companies, healthcare-focused family offices, and experienced operators with clinical backgrounds seeking to build or expand residential treatment portfolios
4–7×
Typical EBITDA multiple
$1M–$5M
Revenue range
Growing
Market trend
SBA Eligible
7(a) financing available
Recession Resistant
Essential service
Buyers typically seek facilities with $1M–$5M revenue, stable occupancy rates above 70%, documented clinical outcomes, clean regulatory and licensing history, diversified payer mix including private pay and commercial insurance, accreditation by CARF or The Joint Commission, and experienced clinical leadership willing to remain post-acquisition
Get Deal Flow In Your Inbox
New Behavioral Health Residential acquisition targets delivered weekly — free to join.
Key items to investigate when evaluating a Behavioral Health Residential acquisition
Seller Intelligence
Who sells Behavioral Health Residential businesses?
Founders and clinician-operators of residential treatment centers for mental health, substance use disorder, or dual diagnosis who are approaching retirement, experiencing burnout, seeking capital for growth, or facing succession challenges without a clear internal heir
Typical exit timeline: 12–24 months
Behavioral Health Residential businesses in the $1M–$5M revenue range typically sell for 4–7× EBITDA. Buyers typically seek facilities with $1M–$5M revenue, stable occupancy rates above 70%, documented clinical outcomes, clean regulatory and licensing history, diversified payer mix including private pay and commercial insurance, accreditation by CARF or The Joint Commission, and experienced clinical leadership willing to remain post-acquisition
Behavioral Health Residential businesses typically trade at 4–7× EBITDA in the lower middle market. The market is highly fragmented with growing demand, which supports premium multiples.
Behavioral Health Residential businesses are SBA 7(a) eligible, making them accessible to first-time buyers. Full asset acquisition with real estate leased separately, seller carry of 10–20% tied to license transfer and census stability over 12–24 months
Key due diligence areas include: State licensure, accreditation status, and regulatory compliance history including any citations or corrective action plans; Payer mix analysis including commercial insurance, Medicaid, Medicare, and private pay revenue concentration; Clinical staffing ratios, licensure credentials, and key person dependency on clinical directors or founders; Referral source diversification and depth of relationships with hospitals, courts, EAPs, and insurance case managers; Billing and collections practices, accounts receivable aging, and historical revenue cycle management performance.
Related Searches
DealFlow OS surfaces acquisition targets, scores seller motivation, and generates outreach — all in one place.
Start finding deals — freeNo credit card required
For Buyers
For Sellers